ITTO20000745A0 - Nuovi acidi naftilsolfonici e composti ad essi correlati utli come agonisti dell'assorbimento del glucosio. - Google Patents
Nuovi acidi naftilsolfonici e composti ad essi correlati utli come agonisti dell'assorbimento del glucosio.Info
- Publication number
- ITTO20000745A0 ITTO20000745A0 IT2000TO000745A ITTO20000745A ITTO20000745A0 IT TO20000745 A0 ITTO20000745 A0 IT TO20000745A0 IT 2000TO000745 A IT2000TO000745 A IT 2000TO000745A IT TO20000745 A ITTO20000745 A IT TO20000745A IT TO20000745 A0 ITTO20000745 A0 IT TO20000745A0
- Authority
- IT
- Italy
- Prior art keywords
- agonists
- new
- compounds useful
- related compounds
- glucose absorption
- Prior art date
Links
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title 1
- 238000010521 absorption reaction Methods 0.000 title 1
- 239000002253 acid Substances 0.000 title 1
- 150000007513 acids Chemical class 0.000 title 1
- 239000000556 agonist Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 239000008103 glucose Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/45—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
- C07C309/51—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/57—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing carboxyl groups bound to the carbon skeleton
- C07C309/59—Nitrogen analogues of carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/12—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
- C07C311/13—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D307/85—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Furan Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14644499P | 1999-07-29 | 1999-07-29 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ITTO20000745A0 true ITTO20000745A0 (it) | 2000-07-28 |
| ITTO20000745A1 ITTO20000745A1 (it) | 2002-01-28 |
Family
ID=22517390
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT2000TO000745A ITTO20000745A1 (it) | 1999-07-29 | 2000-07-28 | Nuovi acidi naftilsolfonici e composti ad essi correlati utli come agonisti dell'assorbimento del glucosio. |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US6653321B1 (it) |
| EP (1) | EP1200396A1 (it) |
| JP (1) | JP2003507361A (it) |
| KR (1) | KR100639544B1 (it) |
| CN (1) | CN1282641C (it) |
| AR (1) | AR031524A1 (it) |
| AU (1) | AU773828B2 (it) |
| BR (1) | BR0012836A (it) |
| CA (1) | CA2377668C (it) |
| CZ (1) | CZ2002234A3 (it) |
| EA (1) | EA006704B1 (it) |
| FR (2) | FR2796942B1 (it) |
| HK (1) | HK1046268B (it) |
| HU (1) | HUP0202168A3 (it) |
| IL (2) | IL147032A0 (it) |
| IT (1) | ITTO20000745A1 (it) |
| MX (1) | MXPA02001023A (it) |
| NO (1) | NO20020425L (it) |
| NZ (1) | NZ516249A (it) |
| PL (1) | PL353359A1 (it) |
| TR (1) | TR200200250T2 (it) |
| TW (1) | TWI256384B (it) |
| UA (1) | UA74555C2 (it) |
| WO (1) | WO2001012591A1 (it) |
| ZA (1) | ZA200200128B (it) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004508348A (ja) * | 2000-09-07 | 2004-03-18 | テリック，インコーポレイテッド | インスリン受容体アクチベーターとしてのベンゼントリカルボン酸誘導対体 |
| US6528037B2 (en) | 2000-10-11 | 2003-03-04 | Telik, Inc. | Method for determining whether a compound is an insulin receptor kinase activator |
| WO2012059442A2 (en) * | 2010-11-01 | 2012-05-10 | Neurotune Ag | Neurotrypsin inhibitors |
| CN104557698A (zh) * | 2015-02-12 | 2015-04-29 | 佛山市赛维斯医药科技有限公司 | 含喹啉基和烷氧苯基结构的葡萄糖激酶活化剂及用途 |
| CN104592112A (zh) * | 2015-02-12 | 2015-05-06 | 佛山市赛维斯医药科技有限公司 | 一类含喹啉和硝基苯结构的葡萄糖激酶活化剂及用途 |
| CN104557695A (zh) * | 2015-02-12 | 2015-04-29 | 佛山市赛维斯医药科技有限公司 | 含喹啉结构的葡萄糖激酶活化剂、制备方法及其用途 |
| CN106831567A (zh) * | 2015-02-12 | 2017-06-13 | 佛山市赛维斯医药科技有限公司 | 含卤代喹啉结构的葡萄糖激酶活化剂、制备方法及其用途 |
| CN104592113A (zh) * | 2015-02-12 | 2015-05-06 | 佛山市赛维斯医药科技有限公司 | 含喹啉和腈基苯结构的葡萄糖激酶活化剂及用途 |
| CN104610143A (zh) * | 2015-02-12 | 2015-05-13 | 佛山市赛维斯医药科技有限公司 | 一种含硝基喹啉结构的葡萄糖激酶活化剂及其用途 |
| CN104557700A (zh) * | 2015-02-12 | 2015-04-29 | 佛山市赛维斯医药科技有限公司 | 一种含腈基喹啉结构的葡萄糖激酶活化剂及其用途 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH488212A (de) | 1967-09-01 | 1970-03-31 | Ciba Geigy | Photographisches Material |
| CA987310A (en) | 1971-04-07 | 1976-04-13 | Ciba-Geigy Ag | Azo dyestuffs, their manufacture and use |
| US4118232A (en) | 1971-04-07 | 1978-10-03 | Ciba-Geigy Ag | Photographic material containing sulphonic acid group containing disazo dyestuffs |
| US4051176A (en) * | 1976-05-10 | 1977-09-27 | American Cyanamid Company | Ureidophenylenebis(carbonylimino)dinaphthalenetrisulfonic acid compounds |
| US4129591A (en) | 1976-10-27 | 1978-12-12 | American Cyanamid Company | Ureida-phenylenebis(substituted imino)multianionic substituted dinaphthalene sulfonic acids and salts |
| US4102917A (en) * | 1977-06-01 | 1978-07-25 | American Cyanamid Company | Substituted phenyl naphthalenesulfonic acids |
| US4132730A (en) * | 1977-07-29 | 1979-01-02 | American Cyanamid Company | Ureylene naphthalene sulfonic acids |
| US4120891A (en) | 1977-07-01 | 1978-10-17 | American Cyanamid Company | Ureylene naphthalene sulfonic acids |
| US4229371A (en) * | 1977-07-29 | 1980-10-21 | American Cyanamid Company | Ureylene naphthalene sulfonic acid intermediates |
| AU2226092A (en) | 1991-06-14 | 1993-01-12 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Azo-dye derivatives exhibiting anti-hiv activity |
| US5589510A (en) | 1994-06-02 | 1996-12-31 | Fuji Immunopharmaceuticals Corp. | Method for inhibiting retroviral infection by administering a naphthalenesulfonic acid compound |
| DE19521589A1 (de) | 1995-06-14 | 1996-12-19 | Bayer Ag | Polyfunktionelle Azoreaktivfarbstoffe |
| ATE296446T1 (de) * | 1997-01-15 | 2005-06-15 | Telik Inc | Modulatoren von insulinrezeptor-aktivität |
-
2000
- 2000-07-28 FR FR0009979A patent/FR2796942B1/fr not_active Expired - Fee Related
- 2000-07-28 AR ARP000103918A patent/AR031524A1/es unknown
- 2000-07-28 IT IT2000TO000745A patent/ITTO20000745A1/it unknown
- 2000-07-28 BR BR0012836-8A patent/BR0012836A/pt not_active Application Discontinuation
- 2000-07-28 JP JP2001516892A patent/JP2003507361A/ja not_active Withdrawn
- 2000-07-28 MX MXPA02001023A patent/MXPA02001023A/es active IP Right Grant
- 2000-07-28 EA EA200200095A patent/EA006704B1/ru not_active IP Right Cessation
- 2000-07-28 KR KR1020027001279A patent/KR100639544B1/ko not_active IP Right Cessation
- 2000-07-28 CA CA002377668A patent/CA2377668C/en not_active Expired - Fee Related
- 2000-07-28 TW TW089115112A patent/TWI256384B/zh not_active IP Right Cessation
- 2000-07-28 TR TR2002/00250T patent/TR200200250T2/xx unknown
- 2000-07-28 HU HU0202168A patent/HUP0202168A3/hu unknown
- 2000-07-28 NZ NZ516249A patent/NZ516249A/xx unknown
- 2000-07-28 US US09/628,206 patent/US6653321B1/en not_active Expired - Fee Related
- 2000-07-28 CZ CZ2002234A patent/CZ2002234A3/cs unknown
- 2000-07-28 AU AU65066/00A patent/AU773828B2/en not_active Ceased
- 2000-07-28 IL IL14703200A patent/IL147032A0/xx active IP Right Grant
- 2000-07-28 CN CNB008109060A patent/CN1282641C/zh not_active Expired - Fee Related
- 2000-07-28 UA UA2002021548A patent/UA74555C2/uk unknown
- 2000-07-28 EP EP00952351A patent/EP1200396A1/en not_active Withdrawn
- 2000-07-28 PL PL00353359A patent/PL353359A1/xx not_active IP Right Cessation
- 2000-07-28 WO PCT/US2000/020909 patent/WO2001012591A1/en active IP Right Grant
-
2001
- 2001-12-11 IL IL147032A patent/IL147032A/en not_active IP Right Cessation
-
2002
- 2002-01-07 ZA ZA200200128A patent/ZA200200128B/xx unknown
- 2002-01-28 NO NO20020425A patent/NO20020425L/no unknown
- 2002-10-24 HK HK02107735.3A patent/HK1046268B/zh not_active IP Right Cessation
- 2002-11-08 FR FR0214025A patent/FR2830531B1/fr not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2015009I2 (el) | Ινδολινονες υποκατεστημενες στη θεση 6, η παραγωγη αυτων και η χρηση αυτων ως φαρμακευτικα μεσα | |
| DE60019577D1 (de) | 4, 5, 6, 7-tetrahydroindazolderivate als antitumormittel | |
| EE200200203A (et) | Südame arütmia ravis kasutatavad uued oksabispidiinühendid | |
| ATE333801T1 (de) | Verbesserungen in der herstellung von tierfutter | |
| IS5582A (is) | Meta-asahringamínóbensósýrusambönd og afleiður þeirra reynast mótlyf við integríni. | |
| ID28483A (id) | 2-(3,5-bis-trifluorometil-fenil)-metil-n-(6-morfolin-4-il-4-0-tolil-piridin-3-il)-isobutiramida | |
| ITTO20000745A0 (it) | Nuovi acidi naftilsolfonici e composti ad essi correlati utli come agonisti dell'assorbimento del glucosio. | |
| ATE327257T1 (de) | Fester, stabiler und konzentrierter biologisch verdaulicher komplex von orthokieselsäure und prozess zur dessen herstellung | |
| ATE309220T1 (de) | Substituierte 1,2,3,4-tetrahydrochinolin-2- carbonsäurederivate | |
| EE200200305A (et) | Südame arütmiate ravis kasutatavad uued asabitsüklooktaani derivaadid | |
| ITMI20000293A0 (it) | Derivati del 3,9-diazabiciclo [3.3.1]nonano ad attivita' analgesica | |
| IT1313700B1 (it) | Composizioni anti-incrostazione e loro impiego nei processi dipolimerizzazione. | |
| IT1319529B1 (it) | Stampo per l'impiego in macchina i.s. | |
| IT1299270B1 (it) | Acidi biliari come induttori del sistema citocromo p450-dipendente, in particolare ad attivita' anticolestatica | |
| IT1312060B1 (it) | Uso dell'acido alfa lipoico nel trattamento antimetastatico. | |
| EE200100675A (et) | Bispidiini uued arütmiavastased ühendid, mida kasutatakse südame arütmia ravis | |
| PT1235809E (pt) | 1,2,3,4,5,6-hexa-hidro-2,6-metano-3-benzazocinas substituidas e sua utilizacao como medicamentos | |
| EE200100674A (et) | Bispidiini uued arütmiavastased ühendid, mida kasutatakse südame arütmia ravis | |
| IT1301786B1 (it) | Composizione anti-incrostazione, e loro impiego nei processi dipolimerizzazione. | |
| EE200100678A (et) | Bispidiini uued arütmiavastased ühendid, mida kasutatakse südame arütmia ravis | |
| ES1042364Y (es) | "pañal perfeccionado". | |
| ES1043175Y (es) | Volquete perfeccionado. | |
| ITRM990414A0 (it) | Derivati perfluorurati di solfonammidi ad attivita' inibitrice dell'anidrasi carbonica, utili in particolare per il trattamento topico del g | |
| ES1042496Y (es) | "pilona sumible". | |
| FI991460A (fi) | Parannettu Ca-N-P-liuoslannoite |